Icosapent ethyl-induced lipoprotein remodeling and its impact on cardiovascular disease risk markers in normolipidemic individuals.

Äikäs L, Kovanen PT, Lorey MB, Laaksonen R, Holopainen M, Ruhanen H, Käkelä R, Jauhiainen M, Hermansson M, Öörni K

DOI: 10.1172/jci.insight.193637
Published: 2025 Oct 8
Container: JCI insight
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci.insight.193637,
  title = {Icosapent ethyl-induced lipoprotein remodeling and its impact on cardiovascular disease risk markers in normolipidemic individuals.},
  author = {Äikäs L and Kovanen PT and Lorey MB and Laaksonen R and Holopainen M and Ruhanen H and Käkelä R and Jauhiainen M and Hermansson M and Öörni K},
  year = {2025},
  journal = {JCI insight},
  doi = {10.1172/jci.insight.193637},
  url = {https://doi.org/10.1172/jci.insight.193637}
}

RIS

TY  - JOUR
TI  - Icosapent ethyl-induced lipoprotein remodeling and its impact on cardiovascular disease risk markers in normolipidemic individuals.
AU  - Äikäs L
AU  - Kovanen PT
AU  - Lorey MB
AU  - Laaksonen R
AU  - Holopainen M
AU  - Ruhanen H
AU  - Käkelä R
AU  - Jauhiainen M
AU  - Hermansson M
AU  - Öörni K
PY  - 2025
JO  - JCI insight
DO  - 10.1172/jci.insight.193637
UR  - https://doi.org/10.1172/jci.insight.193637
ER  -

APA

L, Ä., PT, K., MB, L., R, L., M, H., H, R., R, K., M, J., M, H., & K, Ö. (2025). Icosapent ethyl-induced lipoprotein remodeling and its impact on cardiovascular disease risk markers in normolipidemic individuals.. JCI insight. https://doi.org/10.1172/jci.insight.193637

Source records

pubmed · retrieved 2026-09-26T20:47:54.058Z